Invesco Ltd. bought a new stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 110,441 shares of the company's stock, valued at approximately $5,964,000. Invesco Ltd. owned about 1.19% of Semler Scientific as of its most recent filing with the SEC.
A number of other large investors have also recently bought and sold shares of SMLR. Shariaportfolio Inc. increased its position in Semler Scientific by 4.5% during the fourth quarter. Shariaportfolio Inc. now owns 160,453 shares of the company's stock worth $8,664,000 after buying an additional 6,837 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Semler Scientific by 3.3% during the 4th quarter. Geode Capital Management LLC now owns 140,423 shares of the company's stock valued at $7,584,000 after purchasing an additional 4,464 shares during the last quarter. Thames Capital Management LLC bought a new position in Semler Scientific during the fourth quarter worth $6,465,000. State Street Corp boosted its position in Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company's stock worth $2,784,000 after purchasing an additional 725 shares during the period. Finally, Principal Financial Group Inc. increased its holdings in shares of Semler Scientific by 633.1% in the fourth quarter. Principal Financial Group Inc. now owns 112,487 shares of the company's stock valued at $6,074,000 after purchasing an additional 97,144 shares during the last quarter. Institutional investors and hedge funds own 49.37% of the company's stock.
Analysts Set New Price Targets
Separately, Lake Street Capital upped their target price on Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a research report on Friday, January 24th.
View Our Latest Report on Semler Scientific
Semler Scientific Trading Up 5.0 %
NASDAQ SMLR traded up $1.63 on Thursday, hitting $33.96. 153,326 shares of the company's stock were exchanged, compared to its average volume of 401,134. The stock has a market cap of $325.89 million, a price-to-earnings ratio of 6.92 and a beta of 1.29. The stock has a 50-day moving average of $36.10 and a 200-day moving average of $46.12. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, beating the consensus estimate of $0.20 by $3.21. The company had revenue of $12.41 million during the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
